• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

C221 Biofire image 01

Meningitis/encephalitis panel

, 26 August 2020/in Product News /by 3wmedia

BioFire Diagnostics’ FilmArray Meningitis/ Encephalitis (ME) Panel is now available in the countries which recognize CE marking. The ME Panel provides highly beneficial medical value, as it addresses the critical unmet need for quick and accurate identification of central nervous system (CNS) infectious agents. The comprehensive ME Panel tests cerebrospinal fluid (CSF) for the 14 most common pathogens (6 bacteria, 7 viruses and 1 yeast) responsible for community acquired meningitis or encephalitis in about an hour. Currently, testing CSF for multiple organisms can take days and is not always possible because it can be difficult to obtain enough fluid from each patient to run multiple tests.
The ME Panel received a de novo clearance by the U.S. Food and Drug Administration (FDA) in October 2015. The ME Panel brings a unique opportunity to test simultaneously and rapidly for most bacteria, viruses and fungi found in those pathologies that can be extremely severe and sometimes lethal. Such an approach will positively impact the management of those patients by helping clinicians and biologists speed the diagnosis of these potentially severe conditions and make much faster decisions on appropriate therapy to prevent complications. More than 1.2 million people every year are affected by meningitis worldwide, resulting in 120,000 deaths globally from bacterial meningitis. Bacterial meningitis can occur suddenly in healthy people and even with prompt diagnosis and treatment, approximately 10% of patients may die and up to 20% or more may sustain permanent damage and disability. The ME Panel is cleared for the FilmArray and FilmArray 2.0 systems and is commercially available around the globe.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C221_Biofire-image_01.jpg 512 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:26Meningitis/encephalitis panel
C190 Siemens USE

Personalized learning platform

, 26 August 2020/in Product News /by 3wmedia

Siemens PEPconnect, part of the total Personalized Education Plan (PEP), is the industry’s first personalized education and performance experience for the healthcare professional. With optimized technology and increased search capabilities, PEPconnect allows customers to access education and real-time performance support virtually anytime, anywhere, and on any device, including PCs, laptops, tablets, and smartphones. It enables users to construct a personalized learning experience and easily share and connect with others in their workgroup community. PEPconnect includes over 4,000 competency- based product education and performance support opportunities for healthcare professionals to increase proficiency, as well as general laboratory and clinical applications education events, integrated webinars and seminar and symposium administration and tracking for Siemens-hosted events. The platform delivers comprehensive transcripts with certificates of completion and CEUs. Integration with PEP Administrator and Workgroup Owner is available for existing accounts (whether customer-owned or applications specialists). The PEPConnect platform is available globally in English, with additional languages, including Spanish and Italian, being rolled out by the beginning of November 2015 and all customer languages by March 1, 2016.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C190_Siemens_USE.jpg 125 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:36Personalized learning platform
C158 Coris cropped 01

Klebsiella pneumoniae carbapenemase detection

, 26 August 2020/in Product News /by 3wmedia

To face the tremendous problem of antibiotic-resistant bacteria, Coris BioConcept has developed a new range of tests under the brand name “RESIST”.  Carbapenemase-producing Enterobacteriaceae (CPE) represent a major health concern and any diagnostic tool helping their detection in the laboratory could improve patient safety. A first test (OXA-48 K-SeT) has been launched last March for the detection of OXA-48-like-producing Enterobacteriacae from culture colonies.  After this very successful launch supported by two oral presentations during ECCMID in Copenhagen, a second product is now available for the detection of KPC (Klebsiella pneumoniae carbapenemase) belonging to class A carbapenemases.  It is the most frequent enzyme of this group and shows the highest spreading activity.  This new test, KPC K-SeT, combined with OXA-48 K-SeT will give diagnostic labs the possibility to identify within minutes two of the main carbapenemases observed in Europe.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C158_Coris_cropped_01.jpg 559 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:44Klebsiella pneumoniae carbapenemase detection
C240 Instrumentation lab crop 01

Fully automated on-demand assay for Heparin-Induced Thrombocytopenia

, 26 August 2020/in Product News /by 3wmedia

Instrumentation Laboratory has received FDA clearance for the HemosIL HIT-Ab(PF4-H) assay for use on ACL TOP® Family Hemostasis Testing Systems.  The first, fully automated, on-demand assay for Heparin-Induced Thrombocytopenia (HIT) on a hemostasis testing system, HemosIL HIT-Ab(PF4-H) detects antibodies associated with HIT.   HIT is a severe immunologic adverse reaction to a heparin complex that paradoxically causes blood clots to form, leading to venous and/or arterial thrombosis, and can be fatal.  Diagnosis of HIT is key to positive patient outcomes and may prompt initiation of alternative anticoagulants.  Unlike existing manual processes, HemosIL HIT-Ab(PF4-H) is a liquid, ready-to-use immunoassay that delivers results in minutes—on-demand, 24/7—allowing clinicians to make timely, well-informed therapeutic decisions, essential in critical scenarios.  Management of HIT involves cessation of heparin therapy and initiation of expensive alternative anticoagulants.  Delays in diagnosis caused by prolonged test turnaround time can lead to speculative treatment, increasing bleeding risk for the patient and increasing drug costs, if replacement anticoagulant therapy is used unnecessarily.  Conversely, if patients with HIT remain on heparin while awaiting laboratory confirmation of diagnosis, they may develop more serious complications leading to increased morbidity and mortality.  Therefore, the availability of on-demand HIT antibody testing plays a critical role in better managing HIT, providing results when treatment decisions are needed, and ultimately minimizing patient risk and reducing costs.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C240_Instrumentation-lab_crop_01.jpg 482 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:19Fully automated on-demand assay for Heparin-Induced Thrombocytopenia
CLI Webvertorial Image 2016 RX

Precision, reliability & accuracy in chemistry testing

, 26 August 2020/in Product News /by 3wmedia

The RX series of clinical chemistry analysers has been developed by Randox laboratories to meet & exceed the growing needs of clinical laboratory testing. Robust hardware combined with intuitive software guarantees proven minimal meantime between failures, optimised workflow & the ultimate in precision, reliability and accuracy for results you can trust.

High quality reagents & instrumentation guarantees unrivalled performance, giving you complete confidence in results. Intuitive, easy-to-use software allows real time results for rapid diagnosis & treatment ensuring the best in patient care, while not testing your patience.

We offer astonishing flexibility through our world leading, extensive dedicated test menu allowing routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing to be run on a single platform.

The perfect addition to a variety of laboratory settings, the RX series of semi-automated and fully automated clinical chemistry analysers guarantees cost savings, consolidation and convenience.

For more information please click here
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/CLI-Webvertorial-Image-2016-RX.jpg 150 150 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:29Precision, reliability & accuracy in chemistry testing
C178 Acon labs 01

Automated urine analyser

, 26 August 2020/in Product News /by 3wmedia

Designed for urinalysis testing with the Mission urinalysis reagent strips, the updated Mission U500 analyser includes over 15 strip combinations, 8 builtin languages, and the ability to input colour and clarity all accessible through the new LCD colour touch screen. The Mission U500 urine analyser tests up to 500 tests/hour to fit medium/large volume sample testing. The analyser handles 14 different parameters including Microalbumin, Creatinine, and Calcium. The results are delivered via printouts with the ability to store up to 2,000 test results in the analyser’s memory searchable by test number, patient ID, date, STAT results, and QC results. The Mission U500 urine analyser offers professional accuracy combined with trusted technology, delivering confidence in results in any clinical setting.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C178_Acon-labs_01.jpg 430 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:39Automated urine analyser
C131 Panasonic image1 01

Sample storage freezer

, 26 August 2020/in Product News /by 3wmedia

Panasonic’s Classic Eco MDF-DU300H with hydrocarbon (HC) refrigerants minimizes energy consumption while reducing environmental impact. The introduction of natural HC refrigerants to the latest 333L ULT freezer results in more efficient cooling due to their high latent heat of evaporation. With a power consumption of just 5.9 kWh/day – a 45% reduction compared to equivalent non-HC models – this could lead to potential savings of over €3,000 in energy costs over 10 years. As well as reducing running costs, the use of more efficient refrigerants results in improved performance with reduced pull down times for even greater sample security. Because of their exceptionally low global warming effect, HC refrigerants are also much better for the environment.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C131_Panasonic_image1_01.jpg 800 386 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:47Sample storage freezer
C224 Diasys crop 01

HbA1c enzymatic assay

, 26 August 2020/in Product News /by 3wmedia

The HbA1c value correlates with the average blood glucose level over the last 8-12 weeks and is used for monitoring and diagnosis of diabetes. DiaSys offers HbA1c net FS as a liquid-stable and ready-to-use 2-component assay. Due to the enzymatic test principle, excellent precision is ensured. Interference from a variety of hemoglobin variants like HbS, HbC, HbD, HbE, or HbF can be excluded. HbA1c net FS is characterized by a wide measuring range from 20 to 150 mmol/mol IFCC (4-6% DCCT/NGSP) and high on-board and calibration stability of up to 6 weeks. Moreover, this assay is standardized against the IFCC reference method and traceable according to the DCCT/NGSP network.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C224_Diasys_crop_01.jpg 604 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:24HbA1c enzymatic assay
C171 Sectra 01

Digital pathology system

, 26 August 2020/in Product News /by 3wmedia

Sectra’s solution for storing, viewing and sharing digital pathology images has received the CE mark for primary diagnostic use. The system enables more efficient cancer care by enhancing collaboration and sharing of images between pathologists and radiologists. Pathologists will now be able to review cases digitally on a computer screen, enabling them to eliminate the microscope. The digital format brings new tools to the pathologists’ fingertips and also allows samples to be sent easily to other pathologists to share the workload or for specialist consultations, thereby facilitating quicker and more accurate diagnosis. Pathology and radiology are at the centre of cancer diagnosis and their collective findings are the basis for patient treatment and its outcome. Both disciplines are highly dependent on adequate clinical information in order to provide accurate and useful reports for the clinician, surgeon, oncologist or patient. Despite their joint responsibility for cancer diagnosis, the exchange of information between the two groups is often very limited as the radiology and pathology workflows are usually completely different. Sectra’s system for digital pathology is built on the same platform as its radiology PACS for managing radiology images. The common technical platform enables closer collaboration between the two specialties, sometimes referred to as integrated diagnostics, facilitating, for example, more efficient multi-disciplinary team meetings. Focusing on end-user experience and workflow efficiency, the system provides a platform where images from different hardware vendors can be viewed and archived, and where histology or cytology images can be shown together with macro images. Furthermore, it allows full case overview including integration with other image systems, enabling access to radiology or dermatology data and images in the same workstation. Sectra digital pathology workstation, IDS7/px, consists of a dedicated image window for pathology images and the regular IDS7 information window. The information window includes worklists, full patient information, with possibility to access images from other specialties such as mammography, radiology and dermatology and a reporting window with support for speech recognition. The possibility to reach different types of images, such as pathology and radiology from the same workstation is especially useful for multidisciplinary teams (MDT) meetings. The image window supports the pathologist during review, preparation of MDTs and education and it contains for example tools for text annotations, distance and area measurements. Images from the same block are registered as such and if similar enough are automatically synchronized by the software enabling efficient comparison of the same structure stained with different techniques.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C171_Sectra_01.jpg 533 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:41Digital pathology system
C212 Siemens 01

New assay range including automated TSI

, 26 August 2020/in Product News /by 3wmedia

A range of new assays has been released by Siemens for use on the ADVIA Centaur and IMMULITE XPi 2000 systems. The range includes anti-CCP used as an aid in the evaluation of Rheumatoid Arthritis (RA) and the first automated quantitative thyroid stimulating immunoglobulin (TSI) assay used in the diagnosis of Graves’ disease. The ADVIA Centaur anti-CCP assay is for use in the semi-quantitative determination of the IgG class of autoantibodies specific to cyclic citrullinated peptide (CCP) in human serum and plasma, aiding with the diagnosis of RA. The assay provides 96% specificity for an early accurate diagnosis of RA, ensuring improved patient care by allowing timely intervention and treatment. The Siemens IMMULITE 2000 XPi thyroid stimulating immunoglobulin (TSI) assay specifically detects thyroid stimulating antibodies, which are the hallmark of Graves’ disease, unlike the commonly used TRAb assay which detects both stimulating and blocking antibodies. This makes the assay highly specific, to aid in the disease’s diagnosis. With a clinical sensitivity and specificity of 98.3% and 99.7% respectively, it ensures laboratories can provide a fast, easy and specific diagnosis. The addition of the new assays to the existing extensive range will help laboratory staff integrate testing into routine workflow, reducing the need for send-away testing. This enables laboratories to reduce operational costs and time, as well as becoming more productive and efficient.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C212_Siemens_01.jpg 600 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:18:222021-01-08 11:27:27New assay range including automated TSI
Page 122 of 153«‹120121122123124›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

May 2026

CLi Cover May 2026
18 May 2026

Specific Protein assays for Optilite® Clinical Chemistry analyzers

12 May 2026

ESP September 12-16, 2026 Stockholm, Sweden www.esp-pathology.org

12 May 2026

MEDICA November 16-19, 2026 Dusseldorf, Germany www.medica-tradefair.com

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription